2014
DOI: 10.1002/term.1894
|View full text |Cite
|
Sign up to set email alerts
|

In vitrodevelopment of engineered muscle using a scaffold based on the pressure-activated microsyringe (PAM) technique

Abstract: The development of new human skeletal muscle tissue is an alternative approach to the replacement of tissue after severe damage, for example in the case of traumatic injury, where surgical reconstruction is often needed following major loss of natural tissue. Treatment to date has involved the transfer of muscle tissue from other sites, resulting in a functional loss and volume deficiency of donor sites. Approaches that seek to eliminate these problems include the relatively new solution of skeletal muscle eng… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 41 publications
0
3
0
Order By: Relevance
“…Additive microfabrication techniques such as 3-D printing act by rapidly layering small amounts of material to build structurally detailed scaffolds, and extend scaffold design control to the third dimension [116]. Similarly, pressure activated microsyringe deposition has been utilized to fabricate PLGA and PCL scaffolds with an array of 2-D and 3-D geometries that possess different mechanical properties, which can favor myoblast proliferation or differentiation [117]. For skeletal muscle TE scaffolds, it will be important to understand how the porosity, fiber diameter and density, elasticity, degradation rates, bioactivity and biocompatibility affect both local and systemic host response.…”
Section: Scaffold Materials For Skeletal Muscle Regenerationmentioning
confidence: 99%
“…Additive microfabrication techniques such as 3-D printing act by rapidly layering small amounts of material to build structurally detailed scaffolds, and extend scaffold design control to the third dimension [116]. Similarly, pressure activated microsyringe deposition has been utilized to fabricate PLGA and PCL scaffolds with an array of 2-D and 3-D geometries that possess different mechanical properties, which can favor myoblast proliferation or differentiation [117]. For skeletal muscle TE scaffolds, it will be important to understand how the porosity, fiber diameter and density, elasticity, degradation rates, bioactivity and biocompatibility affect both local and systemic host response.…”
Section: Scaffold Materials For Skeletal Muscle Regenerationmentioning
confidence: 99%
“…It is based on a 3axis micropositioner for the movement in space of different fabrication tools (1 axis, defined as z) respect to a working plane (2 axes, defined as x-y plane) under the control of a dedicated CAD/CAM software. In the present work the air-pressure extrusion system was used, composed by a stainless steel syringe with a glass capillary needle of 80µm diameter [25,26]. Polycaprolactone (PCL), from Sigma Aldrich, was solved in chloroform (Sigma Aldrich) 10% w/v, loaded into the syringe and extruded.…”
Section: Pam 2 Fabricationmentioning
confidence: 99%
“…The fabrication process was finely calibrated: the working parameters were the deposition plane velocity of 9 mm s −1 and extrusion pressure of 8 kPa [25,26].…”
Section: Pam 2 Fabricationmentioning
confidence: 99%